课题基金 / 基金详情

CORELATION BETWEEN HEPATIC SINUSOIDAL ENDOTHELIAL CELLS AND HUMAN COLORECTAL CARCINOMA CELLS IN LIVER METASTASIS

CORELATION BETWEEN HEPATIC SINUSOIDAL ENDOTHELIAL CELLS AND HUMAN COLORECTAL CARCINOMA CELLS IN LIVER METASTASIS
肝窦内皮细胞与人结直肠癌细胞肝转移的相关性
批准号:
09671218
负责人:
SUGIHARA Kenichi
金额:
$1.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

SUGIHARA Kenichi的其他基金

相似基金

相关文献

中文摘要
翻译
Liver是彩色肉瘤(CRC)的Metastasis的主要站点,并且可能有不同的机制来抑制CRC增长。我们已经使用了一种肿瘤细胞-金黄色内皮细胞(SEC)的Coculture系统,以评估SEC对细胞毒性较弱或较强的metastatic CRC细胞。SEC从正常瑞士老鼠的幸存者中分离出来,并被一种门户血管酶增流方法作为单体安装在96孔微滴定板上。Confluent SEC单体包含93%的内皮细胞(由低密度脂蛋白(LDL)受体抑制)和7%的Kupffer细胞。当CRC细胞预先标记为维生素颗粒的红胺-右旋糖胺和钙胺,然后用不饱和的SEC单体体进行鉴定的可行性,克隆细胞的%代谢活动,一个脆弱的Metastatic CRC,显著地低于CX-1细胞,一个高度Metastatic CRC,在培养4小时后(p<0.05)。Pretreatment of SEC gadolinium chloride (GaCl-D23-D2), an inhibitor of KupOracle cell function, did not block the effect of SEC on Clone A cell。在24小时后,Coculture with Clone A, SEC生产了114±5.0 nM nitrite vs 123±5.0和8±2.0的SEC和Clone A细胞单独培养,因此,相应地。Furthermore,当10岁D1-6岁D1至1 mM N-D1 G-D1-甲基-L-精氨酸(NMMA)添加到SEC和克隆的混合物中,克隆一个细胞的毒性被阻断为硝酸生产被抑制超过10岁D1-2岁D1 mM。未刺激的骨髓SEC对较弱的金属克隆一个细胞具有毒性。因此, Hepatic SEC可能是一个主要宿主效应器细胞的种群,即通过较弱的Metastatic CRC,通过硝酸氧化物的生产。
英文摘要
The liver is the major site for metastasis by colorectal carcinoma (CRC) and may have different mechanisms that inhibit CRC growth. We have used a tumor cell-sinusoidal endothelial cell (SEC) coculture system to evaluate whether SEC are cytotoxic to weakly or highly metastatic CRC cells. SEC were isolated from the livers of normal Swiss mice by a portal vein enzymatic infusion method and established as monolayers in 96 well microtiter plates. Confluent SEC monolayers contained 93% endothelial cells (by low density lipoprotein (LDL) receptor staining) and 7% Kupffer cells. When CRC cells were prelabeled with the vital fluorescent dyes rhodamine-dextran and calcein AM and then cocultured with confluent SEC monolayers to assess viability, the % metabolic activity of Clone A cells, a weakly metastatic CRC, was significantly lower than that of CX-1 cells, a highly metastatic CRC, after 4 hrs of coculture (p<0.05). Pretreatment of SEC gadolinium chloride (GaClィイD23ィエD2), an inhibitor of Kupffer cell function, did not block the effect of SEC on Clone A cell. After 24 hrs of coculture with Clone A, SEC produced 114±5.0 nM nitrite vs 123±5.0 and 8±2.0 for SEC and Clone A cells cultured alone, respectively. Furthermore, when 10ィイD1-6ィエD1 to 1 mM NィイD1GィエD1-methyl-L-arginine (NMMA) was added to SEC and Clone A cocultures, toxicity to Clone A cells was blocked as nitrite production was inhibited by dose greater than 10ィイD1-2ィエD1 mM. Unstimulated murine SEC are more toxic to the weakly metastatic Clone A cells than highly metastatic CX-1 cells. Thus, hepatic SEC may be a major host effector cell population that eliminates weakly metastatic CRC through the production of nitric oxide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Urban Planning Support System for Disaster Prevention Utilizing 3D Urban Model
  • 批准号:
    19560542
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2007
  • 负责人:
    SUGIHARA Kenichi
  • 依托单位:
Automatic Generation System for 3-D Urban Model by the Integration of GIS and Computer Vision
  • 批准号:
    16560472
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.37万
  • 财政年份:
    2004
  • 负责人:
    SUGIHARA Kenichi
  • 依托单位:
Cyclooxygenase-2 inhibitor is a possible new drug for treatment of gastrointestinal cancers
  • 批准号:
    16390374
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.62万
  • 财政年份:
    2004
  • 负责人:
    SUGIHARA Kenichi
  • 依托单位:
Automatic Generation System for 3-D Urban ModelSpatial Data
  • 批准号:
    13650607
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $0.51万
  • 财政年份:
    2001
  • 负责人:
    SUGIHARA Kenichi
  • 依托单位:
国内基金
海外基金
Missing in Metastasis基因在子宫内膜癌转移中的机制
  • 批准号:
    81060175
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2010
  • 负责人:
    李崎
  • 依托单位: